Clinical studies monitoring circulating and disseminated tumor cells in gastrointestinal cancers

Folia Histochemica et Cytobiologica

Volumn 51, Issue 4, 2013, Pages 265-277

  Eliasova, Petra ^a,b   Kolostova, Katarina ^a   Kobierzycki, Christopher ^c   Bobek, Vladimir ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Circulating tumor cells; Colorectal cancer; Esophageal cancer; Gastric cancer; Gastrointestinal cancer; Plastin3; Prognosis

Indexed keywords

CLINICAL TRIALS AS TOPIC; GASTROINTESTINAL NEOPLASMS; HUMANS; NEOPLASTIC CELLS, CIRCULATING; TUMOR MARKERS, BIOLOGICAL;

EID: 84893446636     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2013.0037     Document Type: Review

References (87)

1. Steinert G, Scholch S, Koch M et al. Biology and significance of circulating and disseminated tumor cells in colorectal cancer. Langenbecks Arch Surg. 2012;397:535-542.
2. Brechot C et al. Molecular analysis of circulating tumor cells isolated by ISET: A diagnostic approach to improve follow up and treatment of patients with cancer. Boston, World CTC Summit, 2012.
3. Takeuchi H, Kitagawa Y. Detection of circulating tumor cells in gastrointestinal cancer: Has its time come? J Gastrointest Oncol. 2012;3:84-85.
4. Maheswaran S, Haber DA. Circulating tumor cells: a window into cancer biology and metastasis. Curr Opin Genet Dev. 2010;20:96-99.
5. Kin C, Kidess E, Poultsides GA et al. Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis. Expert Rev Mol Diagn. 2013;13:581-599.
6. Negin BP, Cohen SJ. Circulating tumor cells in colorectal cancer: past, present, and future challenges. Curr Treat Options Oncol. 2010;11:1-13.
7. Hiraiwa K, Takeuchi H, Hasegawa H et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol. 2008;15:39092-39100.
8. Moreno JG, O'Hara SM, Gross S et al. Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status. Urology. 2001;58:386-392.
9. Dong X, Alpaugh KR, Cristofanilli M. Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis. Chin J Cancer Res. 2012;24:388-398.
10. Rahbari NN, Bork U, Kircher A et al. Compartmental Differences of Circulating Tumor Cells in Colorectal Cancer. Ann Surg Oncol. 2012;19:2195-2202.
11. Iwanicki-Caron I, Basile P, Toure E et al. Usefulness of Circulating Tumor Cell Detection in Pancreatic Adenocarcinoma Diagnosis. Am J Gastroenterol. 2013;108:152-155.
12. Juratli MA, Sarimollaoglu M, Siegel E et al. Real-time monitoring of circulating tumor-cell release during tumor manipulation using in vivo photoacoustic and fluorescent flow cytometry. Head Neck. 2013; DOI: 10.1002/hed.23439. [Epub ahead of print].
13. Butler TP, Gullino PM. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res. 1975;35:512-516.
14. Jiao LR, Apostolopoulos C, Jacob J et al. Unique localization of circulating tumor cells in patient with hepatic metastases. J Clin Oncol. 2009;36:6160-6165.
15. Wang GY, Li Y, Yu YM et al. Detection of disseminated tumor cells in bone marrow of gastric cancer using magnetic activated cell sorting and fluorescent activated cell sorting. J Gastroenterol Hepatol. 2009;24:299-306.
16. Katayama A, Mafune K, Tanaka Y et al. Autopsy findings in patients after curative esophagectomy for esophageal carcinoma. J Am Coll Surg. 2003;196:866-873.
17. Liu Z, Jiang M, Zhao J et al. Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility. Clin Cancer Res. 2007;13:2992-2997.
18. Vashist YK, Effenberger KE, Vettorazzi E et al. Disseminated tumor cells in bone marow and the natural course of resected esophageal cancer. Ann Surg. 2012;255:1105-1112.
19. Yin XD, Yuan X, Xue JJ et al. Clinical significance of carcinoembryonic antigen-, cytokeratin 19-, or survivin-positive circulating tumor cells in the peripheral blood of esophageal squamous cell carcinoma patients treated with radiotherapy. Dis Esophagus. 2012;25:750-756.
20. Zhang ZY, Ge HY. Micrometastasis in gastric cancer. Cancer Lett. 2013;336:34-45.
21. Arigami T, Uenosono Y, Hirata M et al. B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells. Cancer Sci. 2011;102:1019-1024.
22. Saad AA, Awed NM, Abd Elkerim NN et al. Prognostic significance of E-cadherin expression and peripheral blood micrometastasis in gastric carcinoma patients. Ann Surg Oncol. 2010;17:3059-3067.
23. Pituch-Noworolska A, Kolodziejczyk P, Kulig J et al. Circulating tumour cells and survival of patients with gastric cancer. Anticancer Res. 2007;27:635-640.
24. Yeh KH, Chen YC, Yeh SH et al. Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19)-possible clinical significance in advanced gastric cancer. Anticancer Res. 1998;18:1283-1286.
25. Koga T, Tokunaga E, Sumiyoshi Y et al. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. Hepatogastroenterology. 2008;84:1131-1135.
26. Illert B, Fein M, Otto C et al. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis. Scand J Gastroenterol. 2005;40:843-849.
27. Uen YH, Lin SR, Wu CH et al. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma. Clin Chim Acta. 2006;367:55-61.
28. Matsusaka S, Chìn K, Ogura M et al. Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer. Cancer Sci. 2010;101:1067-1071.
29. Bertazza L, Mocellin S, Marchet A et al. Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival. J Transl Med. 2009;7:111.
30. Cao W, Yang W, Li H et al. Using detection of survivin-expressing circulating tumor cells in peripheral blood to predict tumor recurrence following curative resection of gastric cancer. J Surg Oncol. 2011;103:110-115.
31. Cohen SJ, Alpaugh RK, Gross S et al. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Cancer. 2006;6:125-132.
32. Sastre J, Maestro ML, Gomez-Espana A et al. Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study. Oncologist. 2012;17:947-955
33. Molnar B, Ladanyi A, Tanko L et al. Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. Clin Cancer Res. 2001;12:4080-4085.
34. Yokobori T, Iinuma H, Shimamura T et al. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res. 2013;73:2059-2069.
35. Torino F, Bonmassar E, Bonmassar L et al. Circulating tumor cells in colorectal cancer patients. Cancer Treat Rev. 2013;39:759-772.
36. Rahbari NN, Aigner M, Thorlund K et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology. 2010;138:1714-1726.
37. Groot Koerkamp B, Rahbari NN, Buchler MW et al. Circulating tumor cells and prognosis of patients with resectable colorectal liver metastase or widespread metastatic colorectal cancer: a meta-analysis. Ann Surg Oncol. 2013;20:2156-2165.
38. Katsuno H, Zacharakis E, Aziz O et al. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis. Ann Surg Oncol. 2008;15:3083-3091.
39. Neki K, Kawahara H, Watanabe K et al. Usefulness of circulating tumor cells after preliminary chemotherapy for prediction of response to further anticancer therapy in patients with initially unresectable metastatic colorectal cancer. Anticancer Res. 2013;33:1769-1772.
40. Uen YH, Lu CY, Tsai HL et al. Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection. Ann Surg Oncol. 2008;15:2120-2128.
41. Lu CY, Uen YH, Tsai HL et al. Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse. Br J Cancer. 2011;104:1178-1184.
42. Lankiewicz S, Zimmermann S, Hollmann C et al. Circulating tumour cells as a predictive factor for response to systemic chemotherapy in patients with advanced colorectal cancer. Mol Oncol. 2008;3:349-355.
43. Gazzaniga P, Gradilone A, Petracca A et al. Molecular markers in circulating tumour cells from metastatic colorectal cancer patients. J Cell Mol Med. 2010;14:2073-2077.
44. Kolodziejczyk P, Pituch-Noworolska A, Drabik G et al. The effects of preoperative chemotherapy on isolated tumor cells in the blood and bone marrow of gastric cancer patients. Br J Cancer. 2007;97:589-592.
45. de Albuquerque A, Kubisch I, Ernst D et al. Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients. Clin Lab. 2012;58:373-384.
46. Hoffmann AC, Vallbohmer D, Prenzel K et al. Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome. J Cancer Res Clin Oncol. 2009;135:1231-1237.
47. Brabender J, Vallbohmer D, Grimminger P et al. ERCC1 RNA expression in peripheral blood predicts minor histopathological response to neoadjuvant radio-chemotherapy in patients with locally advanced cancer of the esophagus. J Gastrointest Surg. 2008;12:1815-1821.
48. Hoffmann AC, Warnecke-Eberz U, Luebke T et al. Survivin mRNA in peripheral blood is frequently detected and significantly decreased following resection of gastrointestinal cancers. J Surg Oncol. 2007;95:51-54.
49. Ikoma D, Ichikawa D, Ueda Y et al. Circulating tumor cells and aberrant methylation as tumor markers in patients with esophageal cancer. Anticancer Res. 2007;27:535-539.
50. Hoffmann AC, Warnecke-Eberz U, Luebke T et al. Survivin mRNA in peripheral blood is frequently detected and significantly decreased following resection of gastrointestinal cancers. J Surg Oncol. 2007;95:51-54.
51. Ikeguchi M, Kaibara N. Detection of circulating cancer cells after a gastrectomy for gastric cancer. Surg Today. 2005;35:436-441.
52. Ito H, Kanda T, Nishimaki T et al. Detection and quantification of circulating tumor cells in patients with esophageal cancer by real-time polymerase chain reaction. J Exp Clin Cancer Res. 2004;23:455-464.
53. Kaganoi J, Shimada Y, Kano M et al. Detection of circulating oesophageal squamous cancer cells in peripheral blood and its impact on prognosis. Br J Surg. 2004;91:1055-1060.
54. Huang P, Wang J, Guo Y et al. Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer. J Cancer Res Clin Oncol. 2003;129:192-198.
55. Nakashima S, Natsugoe S, Matsumoto M et al. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer. Surgery. 2003;133:162-169.
56. Koike M, Hibi K, Kasai Y et al. Molecular detection of circulating esophageal squamous cell cancer cells in the peripheral blood. Clin Cancer Res. 2002;8:2879-2882.
57. Miyazono F, Natsugoe S, Takao S et al. Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery. Ann Surg. 2001;233:189-194.
58. Soeth E, Vogel I, Roder C et al. Comparative analysis of bone marrow and venous blood isolated from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res. 1997;57:3106-3110.
59. Galletti G, Sung MS, Vahdat LT et al. Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device. Lab Chip. 2014;14:147-156.
60. Sato N, Hayashi N, Imamura Y et al. Usefulness of Transcription-Reverse Transcription Concerted Reaction Method for Detecting Circulating Tumor Cells in Patients With Colorectal Cancer. Ann Surg Oncol. 2012;19:2060-2065.
61. Aggarwal C, Meropol NJ, Punt CJ et al. Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. Ann Oncol. 2013;24:420-428.
62. Flatmark K, Borgen E, Nesland JM et al. Disseminated tumour cells as a prognostic biomarker in colorectal cancer. Br J Cancer. 2011;104:1434-1439.
63. Matsusaka S, Suenaga M, Mishima Y et al. Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer. Cancer Chemother Pharmacol. 2011;68:763-768.
64. Tol J, Koopman M, Miller MC et al. Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Ann Oncol. 2010;5:1006-1012.
65. Papavasiliou P, Fisher T, Kuhn J et al. Circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Baylor Univ Med Cent Proc. 2010;23:11-14.
66. Konigsberg R, Gneist M, Jahn-Kuch D et al. Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods. Cancer Lett. 2010;293:117-123.
67. Marrinucci D, Bethel K, Lazar D et al. Cytomorphology of Circulating Colorectal Tumor Cells: A Small Case Series. J Oncol. 2010;2010:861341.
68. Maestro LM, Sastre J, Rafael SB et al. Circulating Tumor Cells in Solid Tumor in Metastatic and Localized Stages. Anticancer Res. 2009;29:4839-4843.
69. Wong SC, Chan CM, Ma BB et al. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients. Clin Cancer Res. 2009;15:1005-1012.
70. Cohen SJ, Punt CJ, Iannotti N et al. Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer. J Clin Oncol. 2008;26:3213-3221.
71. Schoppmeyer K, Fruhauf N, Oldhafer K et al. Tumor cell dissemination in colon cancer does not predict extrahepatic recurrence in patients undergoing surgery for hepatic metastases. Oncol Rep. 2006;15:449-454.
72. Barbazan J, Alonso-Alconada L, Muinelo-Romay L et al. Molecular Characterization of Circulating Tumor Cells in Human Metastatic Colorectal Cancer. PLoS One. 2012;7:e40476.
73. Iinuma H, Watanabe T, Mimori K et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J Clin Oncol. 2011;29:1547-1555.
74. Vogelaar FJ, Mesker WE, Rijken AM et al. Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study. BMC Cancer. 2010;10:153.
75. Yen LC, Yeh YS, Chen CW et al. Detection of KRAS oncogene in peripheral blood as a predictor of the response to cetuximab plus chemotherapy in patients with metastatic colorectal cancer. Clin Cancer Res. 2009;15:4508-4513.
76. Koyanagi K, Bilchik AJ, Saha S et al. Prognostic Relevance of occulat nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Cli Cancer Res. 2008;22:7391-7396.
77. Zieglschmid V, Hollmann C, Mannel J et al. Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer. Anticancer Res. 2007;27:1823-1832.
78. Allen-Mersh TG, McCullough TK, Patel H et al. Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma. Br J Surg. 2007;94:96-105.
79. Wang JY, Lin SR, Wu DC et al. Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels. Clin Canc Res. 2007;13:2406-2413.
80. Sadahiro S, Suzuki T, Maeda Y et al. Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer. Ann Surg Oncol. 2007;14:1092-1098.
81. Iinuma H, Okinaga K, Egami H et al. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int J Oncol. 2006;28:297-306.
82. Koch M, Kienle P, Hinz U et al. Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases. Ann Surg. 2005;241:199-205.
83. Staritz P, Kienle P, Koch M et al. Detection of disseminated tumour cells as a potential surrogate-marker for monitoring palliative chemotherapy in colorectal cancer patients. J Exp Clin Cancer Res. 2004;23:633-639.
84. Vlems FA, Diepstra JH, Punt CJ et al. Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer. Br J Surg. 2003;90:989-995.
85. Ito S, Nakanishi H, Hirai T et al. Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler. Cancer Lett. 2002;183:195-203.
86. Patel H, Le Marer N, Wharton RQ et al. Clearance of circulating tumor cells after excision of primary colorectal cancer. Ann Surg. 2002;235:226-231.
87. Wyld DK, Selby P, Perren TJ et al. Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer. 1998;79:288-293.